Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 826 AL 840

Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson's disease mouse model

Kim Y, Vaidya B, Kim J, Bitar S, Shajan FJ, Verma AK, Yalamanchili HK, Singh S, Zoghbi HY.

bioRxiv [Preprint]. 2026 Jun 8:2026.05.20.726454. doi: 10.64898/2026.05.20.726454.

Deubiquitinases at organelle quality control bottlenecks in neurodegeneration

Ellerby LM, Ashkenazi A.

Trends Mol Med. 2026 Jul;32(7):624-627. doi: 10.1016/j.molmed.2026.05.006. Epub 2026 Jun 4.

Exercise and smoking: health rivals revealing shared protective mechanisms in Parkinson's?

Janssen Daalen JM, Schootemeijer S, Oosterhof T, Ripping JM, Bloem BR, Gomperts SN, Schwarzschild MA.

NPJ Parkinsons Dis. 2026 Jun 4;12(1):137. doi: 10.1038/s41531-026-01424-6.

Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review

Meneghini C, Gallo L, Sala A, Valente EM, Avenali M, Caminiti SP.

Mov Disord Clin Pract. 2026 Oct;13(10):2379-2394. doi: 10.1002/mdc3.70687. Epub 2026 Jun 4.

Multifunctional Nanoparticles for Theranostics of Protein Misfolding Diseases: A Systematic Review

Tariq H, Khan S, Shahid H, Sohail T, Noor A.

J Biomed Mater Res B Appl Biomater. 2026 Jun;114(6):e70106. doi: 10.1002/jbm.b.70106.

The NTR/prodrug revolution: Tools for controlling cell loss and regeneration

Kim GJ, Parsons M.

Elife. 2026 Jun 5;15:RP110593. doi: 10.7554/eLife.110593.

The role of Th17 cells in the pathogenesis of Parkinson's disease: From immune dysregulation to neurodegeneration

Zhao J, Liang H, Bi Y.

Brain Res Bull. 2026 Aug;242:111990. doi: 10.1016/j.brainresbull.2026.111990. Epub 2026 Jun 4.

Periodontal health in a longitudinal French cohort of people with Parkinson's disease

Samot J, Courtin E, Guehl D, Damon-Perriere N, Branchard O, Saint-Jean M, Chuy V, Ella B, Badet MC.

Sci Rep. 2026 Jun 5;16(1):25752. doi: 10.1038/s41598-026-55641-3.

Parkinsonism in KMT5B-Related Disorders: Expanding the Spectrum

Rábano-Suárez P, Sánchez-Ferro Á, Arteche-López A, Quesada JF, Pérez de la Fuente R, Morales M, Jiménez Díez-Canseco L, Galiana Á, Méndez-Guerrero A.

Mov Disord Clin Pract. 2026 Oct;13(10):2617-2620. doi: 10.1002/mdc3.70701. Epub 2026 Jun 6.

The social cost of facial bradykinesia: a scoping review of interpersonal outcomes related to Parkinsonian hypomimia

Datinguinoo JLC, Rosales RL, Obien ECF.

J Neural Transm (Vienna). 2026 Jun 6. doi: 10.1007/s00702-026-03190-4. Online ahead of print.

Machine Learning and Deep Learning for Neurological Disease Analysis: A Systematic Review Across Five Major Disorders

Uddin KN, Ghose P, Njie E, Mahmood N, Kumar N, Haque MN, Gaur L, Li A, Mallik S.

Neuroscience. 2026 Aug 28;610:55-90. doi: 10.1016/j.neuroscience.2026.05.036. Epub 2026 Jun 5.

Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases

Zhao X, Fu YT, Qiu NZ, Pan YX, Zhang HT, Wang H.

Cell Signal. 2026 Oct;146:112654. doi: 10.1016/j.cellsig.2026.112654. Epub 2026 Jun 6.

Impact of DSP4-induced locus coeruleus dysfunction on sleep: Systematic review and methodology

Knopper RW, Hansen B.

Neurobiol Dis. 2026 Sep;227:107457. doi: 10.1016/j.nbd.2026.107457. Epub 2026 Jun 6.

PET Molecular Probes for Neuroinflammation in Neurodegenerative Diseases: Progress and Prospects

Jin H.

ACS Chem Neurosci. 2026 Jun 17;17(12):2229-2237. doi: 10.1021/acschemneuro.6c00338. Epub 2026 Jun 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias